BIOTRON LIMITED(BIT.AU)

0.00+0.000.00%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
BIOTRON LIMITED
Market
ASX
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.biotron.com.au
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Limited is based in North Ryde, Australia.

1D
5D
Day
Week
Month

Loading ...

High

0.00

Open

0.00

Volume%

0.00

Low

0.00

Close

0.00

T/O Rate

0.00%

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"pagemeta":{"title":"BIOTRON LIMITED(BIT.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BIOTRON LIMITED(BIT.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BIOTRON LIMITED,BIT.AU,BIOTRON LIMITED股票,BIOTRON LIMITED股票老虎,BIOTRON LIMITED股票老虎国际,BIOTRON LIMITED行情,BIOTRON LIMITED股票行情,BIOTRON LIMITED股价,BIOTRON LIMITED股市,BIOTRON LIMITED股票价格,BIOTRON LIMITED股票交易,BIOTRON LIMITED股票购买,BIOTRON LIMITED股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BIOTRON LIMITED(BIT.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BIOTRON LIMITED(BIT.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"summary","symbol":"BIT.AU","data":{"stockData":{"symbol":"BIT.AU","market":"AU","secType":"STK","nameCN":"BIOTRON LIMITED","latestPrice":0.003,"timestamp":1742361120000,"preClose":0.003,"halted":0,"volume":0,"delay":0,"nameEN":"BIOTRON LIMITED","floatShares":698777059,"shares":902382766,"eps":-0.001569,"marketStatus":"Not Yet Opened","change":0,"latestTime":"03-19 16:12:00 AEDT","open":0.003,"high":0.003,"low":0.003,"amount":0,"amplitude":0,"askPrice":0.004,"askSize":4088629,"bidPrice":0.003,"bidSize":20037481,"shortable":3,"etf":0,"ttmEps":-0.001569,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1742425200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.003,"openAndCloseTimeList":[[1742338800000,1742360400000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.biotron.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.6667},{"period":"3month","weight":-0.7857},{"period":"6month","weight":-0.8235},{"period":"1year","weight":-0.9524},{"period":"ytd","weight":-0.8125}],"compareEarnings":[{"period":"1week","weight":0.0212},{"period":"1month","weight":0.0432},{"period":"3month","weight":0.0933},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.2293},{"period":"ytd","weight":0.0994}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also has a portfolio of preclinical antiviral programs developing drugs targeting a range of viral diseases, including Dengue, Zika, Influenza, Ebola, and SARs. Biotron Limited is based in North Ryde, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.28,"avgChangeRate":-0.06298},{"month":2,"riseRate":0.44,"avgChangeRate":-0.015344},{"month":3,"riseRate":0.25,"avgChangeRate":-0.078199},{"month":4,"riseRate":0.458333,"avgChangeRate":0.049404},{"month":5,"riseRate":0.125,"avgChangeRate":-0.140956},{"month":6,"riseRate":0.583333,"avgChangeRate":0.110905},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.016245},{"month":8,"riseRate":0.25,"avgChangeRate":0.059053},{"month":9,"riseRate":0.541667,"avgChangeRate":0.150596},{"month":10,"riseRate":0.333333,"avgChangeRate":0.024497},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.002804},{"month":12,"riseRate":0.458333,"avgChangeRate":0.033506}],"exchange":"ASX","name":"BIOTRON LIMITED","nameEN":"BIOTRON LIMITED"},"aProfile":null}}}